Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria

Acta Diabetologica

Volumn 46, Issue 4, 2009, Pages 309-316

  BarIş, Necla ^a   Erdoǧan, Mehmet ^a   Sezer, Ebru ^a   SaygIlI, Füsun ^a   Mert Ozgonul A ^a   Turgan, Nevbahar ^a   Ersöz, Biltan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Cardiovascular risk; Endothelial function; Hs CRP; L Arginine; Microalbuminuria; Neopterin

Indexed keywords

ARGININE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; MARKER; NEOPTERIN;

ADULT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIABETIC PATIENT; ENDOTHELIUM CELL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

ALBUMINURIA; ARGININE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPTERIN;

EID: 70449528738     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-008-0089-9     Document Type: Article

References (29)

1. H Trachtman S Futterweit E Pine J Mann E Valderrama 2002 Chronic diabetic nephropathy: role of inducible nitric oxide synthase Pediatr Nephrol 17 20 29 10.1007/s004670200004 11793130 (Pubitemid 41490200)
2. DJ Fraser AO Phillips 2007 Diabetic nephropathy Medicine 35 9 503 506 10.1016/j.mpmed.2007.06.007 (Pubitemid 47307236)
3. AN Friedman LG Hunsicker J Selhub AG Bostom 2004 Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy Atherosclerosis 172 121 125 10.1016/j.atherosclerosis.2003.09.011 1:CAS:528:DC%2BD2cXovVGl 14709365 (Pubitemid 38058609)
4. R Pecoits-Filho LC Sylvestre P Stenvinkel 2005 Chronic kidney disease and inflammation in pediatric patients: from bench to playground Pediatr Nephrol 20 714 720 10.1007/s00467-005-1891-z 15856313 (Pubitemid 40663151)
5. MB Pepys GM Hirschfield 2003 C-reactive protein: a critical update J Clin Invest 111 1805 1812 1:CAS:528:DC%2BD3sXkvV2ktb0%3D 12813013
6. ETH Yeh 2004 CRP as a mediator of disease Circulation 109 Suppl II 11 14
7. HY Lhee H Kim KJ Joo SS Jung KB Lee 2006 The clinical significance of serum and urinary neopterin levels in several renal diseases J Korean Med Sci 21 678 682 1:CAS:528:DC%2BD28XpvVClsLk%3D 16891812
8. G Hoffmann B Wirleitner D Fuchs 2003 Potential role of immune system activation-associated production of neopterin derivatives in humans Inflam Res 52 313 321 10.1007/s00011-003-1181-9 1:CAS:528:DC%2BD3sXntlSiu7Y%3D (Pubitemid 36995156)
9. G Siasos D Tousoulis C Antoniades E Stefanadi C Stefanadis 2007 l-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int J Cardiol 116 3 300 308 10.1016/j.ijcard.2006.04. 062 16860889 (Pubitemid 46283019)
10. JD Mendez FL Balderas 2006 Inhibition by l-arginine and spermidine of hemoglobin glycation and lipid peroxidation in rats with induced diabetes Biomed Pharmacother 60 1 26 31 10.1016/j.biopha.2005.08.004 1:CAS:528: DC%2BD2MXhtlCrs7bF 16337106 (Pubitemid 41821215)
11. A Kabat S Dhein 2006 l-arginine supplementation prevents the development of endothelial dysfunction in hyperglycaemia Pharmacology 78 185 191 10.1159/000091606
12. PA Sarafidis LM Ruilope 2006 Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications Am J Nephrol 26 3 232 244 10.1159/000093632 16733348 (Pubitemid 44114394)
13. JPF Chin-Dusting L Willems DM Kaye 2007 l-Arginine transporters in cardiovascular disease: a novel therapeutic target Pharmacol Ther 116 428 436 10.1016/j.pharmthera.2007.08.001 1:CAS:528:DC%2BD2sXhtlCrs7bI 17915331 (Pubitemid 350116940)
14. American Diabetes Association 2008 Position statement. Standards of Medical Care in Diabetes Diabetes Care 31 suppl 1 S12 S54 10.2337/dc08-S012
15. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr EJ Roccella 2003 The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560 2572 10.1001/jama.289.19. 2560 1:CAS:528:DC%2BD3sXjvFCqtrk%3D 12748199 (Pubitemid 37430158)
16. JW Meijer AJ Smit EV Sonderen JW Groothoff WH Eisma TP Links 2002 Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score Diabet Med 19 11 962 965 10.1046/j.1464-5491.2002. 00819.x 1:STN:280:DC%2BD38nmtFKrtA%3D%3D 12421436 (Pubitemid 35356925)
17. N Turgan S Habif Z ParIldar D Ozmen I Mutaf D Erdener O Bayindir 2001 Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC-fluorometric method Clin Biochem 33 271 275 10.1016/S0009-9120(01) 00226-0 (Pubitemid 32607568)
18. RF Adams 1974 Amino acids J Chromatogr 95 1286 1315 10.1016/S0021- 9673(00)84078-9
19. MB Gomes VG Nogueira 2004 Acute-phase proteins and microalbuminuria among patients with type 2 diabetes Diabetes Res Clin Pract 66 1 31 39 10.1016/j.diabres.2004.02.009 1:CAS:528:DC%2BD2cXnsFSltrk%3D 15364159 (Pubitemid 39201369)
20. D Aronson P Bartha O Zinder A Kerner E Shitman W Markiewicz GJ Brook Y Levy 2004 Association between fasting glucose and CRP in middle-aged subjects Diabet Med 21 39 44 10.1046/j.1464-5491.2003.01084.x 1:CAS:528: DC%2BD2cXhs1Grt7c%3D 14706052 (Pubitemid 38168027)
21. NA Abdella OA Mojiminiyit MA Moussa M Zaki H Al Mohammedi ES Al Ozairi S Al Jebely 2005 Plasma leptin concentrations in patients with type 2 diabetes: relationship to cardiovascular risk factors and insulin resistance Diabet Med 22 278 285 10.1111/j.1464-5491.2004.01405.x 1:CAS:528:DC%2BD2MXisFCqsrY%3D 15717875 (Pubitemid 40313854)
22. C Tsioufis K Dimitriadis E Taxiarchou C Vasiliadou G Chartzoulakis D Tousoulis A Manolis C Stefanadis I Kallikazaros 2006 Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects Am J Hypertens 19 5 462 466 10.1016/j.amjhyper.2005.07.026 1:CAS:528:DC%2BD28Xjsl2lsr4%3D 16647614 (Pubitemid 44389665)
23. CD Stehouwer YM Smulders 2006 Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms J Am Soc Nephrol 17 8 2106 2111 10.1681/ASN.2005121288 1:CAS:528:DC%2BD28XosFalsbc%3D 16825333 (Pubitemid 44141899)
24. A Ceriello C Taboga L Tonutti L Quagliaro L Piconi B Bais R Da Ros E Motz 2002 Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation effects of short- and long-term simvastatin treatment Circulation 106 1211 1218 10.1161/01.CIR.0000027569.76671.A8 12208795 (Pubitemid 34988638)
25. M Negrean A Stirban B Stratmann T Gawlowski T Horstmann C Götting K Kleesiek M Michaela Mueller-Roesel T Koschinsky J Uribarri H Vlassara D Tschoepe 2007 Effects of low- and high-advanced glycation end product meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am J Clin Nutr 85 5 1236 1243 1:CAS:528: DC%2BD2sXls1Kiur4%3D 17490958
26. S Gupta S Fredericks RA Schwartzman JC Kaski 1997 Serum neopterin in acute coronary syndromes Lancet 349 1252 1253 10.1016/S0140-6736(05)62447-6 1:STN:280:DyaK2s3nslGrtw%3D%3D 9130969
27. I Anwaar A Gottsater KF Eriksson L Jacobsson F Lindgärde I Mattiasson 2000 Increased plasma enothelin-1 and intraplatelet cGMP in men with disturbed glucose metabolism Diabetes Res Clin Pract 50 127 136 10.1016/S0168-8227(00)00190-X 1:CAS:528:DC%2BD3cXlvV2nsLw%3D 10960723 (Pubitemid 30674212)
28. MF Weiss RA Rodby AC Justice DE Hricik 1998 The Collaborative Study Group. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy Kidney Int 54 193 202 1:CAS:528:DyaK1cXksVyhsLg%3D 9648079
29. S Klahr J Morrissey 2004 l-arginine as a therapeutic tool in kidney disease Semin Nephrol 24 4 389 394 10.1016/j.semnephrol.2004.04.010 1:CAS:528:DC%2BD2cXntVeksLg%3D 15252778 (Pubitemid 38900638)